Anzalone, Andrew V.
Randolph, Peyton B.
Davis, Jessie R.
Sousa, Alexander A.
Koblan, Luke W.
Levy, Jonathan M.
Chen, Peter J.
Wilson, Christopher
Newby, Gregory A.
Raguram, Aditya
Liu, David R.
Article History
Received: 26 August 2019
Accepted: 10 October 2019
First Online: 21 October 2019
Competing interests
: Authors through the Broad Institute have filed patent applications on prime editing. D.R.L. is a consultant and co-founder of Prime Medicine, Beam Therapeutics, Pairwise Plants, and Editas Medicine, companies that use genome editing.